已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yuhang发布了新的文献求助10
1秒前
1秒前
木木发布了新的文献求助10
1秒前
一切都好完成签到 ,获得积分10
3秒前
sajid完成签到,获得积分10
4秒前
5秒前
yu发布了新的文献求助10
6秒前
Jane完成签到,获得积分10
6秒前
6秒前
杨晓柳发布了新的文献求助10
9秒前
早安完成签到 ,获得积分10
10秒前
qwe402完成签到 ,获得积分10
17秒前
852应助诚心山芙采纳,获得10
17秒前
丘比特应助Whisper采纳,获得10
18秒前
20秒前
香蕉觅云应助美丽狗狗公主采纳,获得100
21秒前
天天快乐应助yusong采纳,获得10
22秒前
23秒前
SciGPT应助未闻星名采纳,获得10
24秒前
石子完成签到 ,获得积分10
26秒前
28秒前
better完成签到 ,获得积分10
29秒前
F7erxl完成签到,获得积分10
30秒前
30秒前
EWFDSC完成签到 ,获得积分10
32秒前
32秒前
32秒前
拼搏一下发布了新的文献求助10
32秒前
35秒前
科研通AI6.2应助aaaa采纳,获得10
36秒前
阿六发布了新的文献求助10
37秒前
诚心山芙发布了新的文献求助10
37秒前
yusong发布了新的文献求助10
37秒前
39秒前
RogerCHEN完成签到 ,获得积分10
39秒前
义气的熊猫完成签到,获得积分10
42秒前
乐乐应助qaz123采纳,获得10
43秒前
44秒前
Kretschmann完成签到,获得积分0
44秒前
诚心的笑南完成签到 ,获得积分10
47秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
适配Micro-LED色转换的高兼容性量子点负性光刻胶制备与工艺研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7316918
求助须知:如何正确求助?哪些是违规求助? 8932775
关于积分的说明 18936587
捐赠科研通 6976757
什么是DOI,文献DOI怎么找? 3214133
关于科研通互助平台的介绍 2382037
邀请新用户注册赠送积分活动 2192916